Home › NDC Lookup › RxCUI directory › RxCUI 1251365

Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon] — RxCUI 1251365

RxNorm drug concept · Semantic branded drug
RxCUI 1251365 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1251365
Official nameAluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asGaviscon (aluminum hydroxide 95 MG / magnesium carbonate 358 MG) per 15 ML Oral Suspension; Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension; Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
FDA products mapped3
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aluminum Hydroxide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. The oral liquid is an antacid — you take it by mouth to relieve heartburn, acid indigestion, and sour stomach. ProCure DryDrox is a completely different...
  • What is aluminum hydroxide actually used for?
  • Give the bottle a good shake before every use — that's important. Take 2 teaspoonfuls up to 5 to 6 times a day, after meals and at bedtime, followed by a small sip of water if you...
  • How do I take the oral liquid correctly?
📖 Read our full Aluminum Hydroxide guide →

🕸️ Concept Web — How Aluminum hydroxide 6.33 MG/ML / magnesium carbon... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon] RxCUI 1251365

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Aluminum hydroxide 612
    • Magnesium carbonate 29155
    • Aluminum hydroxide / magnesium carbonate 1029441
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gaviscon 25655
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aluminum hydroxide / magnesium carbonate Oral Suspension 370832
    • Aluminum hydroxide / magnesium carbonate Oral Liquid Product 1155939
    • Aluminum hydroxide / magnesium carbonate Oral Product 1155940
    • Aluminum hydroxide / magnesium carbonate Oral Suspension [Gaviscon] 366007
    • Gaviscon Oral Liquid Product 1167118
    • Gaviscon Oral Product 1167119
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension SCD · 252203
  • Aluminum hydroxide 6.33 MG/ML SCDC · 331000
  • Magnesium carbonate 23.9 MG/ML SCDC · 331001
  • Aluminum hydroxide / magnesium carbonate Oral Suspension SCDF · 370832
  • Aluminum hydroxide / magnesium carbonate Oral Liquid Product SCDG · 1155939
  • Aluminum hydroxide / magnesium carbonate Oral Product SCDG · 1155940

Brand-Name Concepts

  • Aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon] SBDC · 1251364
  • Aluminum hydroxide / magnesium carbonate Oral Suspension [Gaviscon] SBDF · 366007
  • Gaviscon Oral Liquid Product SBDG · 1167118
  • Gaviscon Oral Product SBDG · 1167119
  • Gaviscon BN · 25655

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 1251365 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00135-0094-41 355 mL in 1 BOTTLE (0135-0094-41) GAVISCON Haleon US Holdings LLC 2011-01-14
00135-0094-42 177 mL in 1 BOTTLE (0135-0094-42) GAVISCON Haleon US Holdings LLC 2011-01-14
00135-0095-41 355 mL in 1 BOTTLE (0135-0095-41) GAVISCON Haleon US Holdings LLC 2011-01-14
00135-0574-01 355 mL in 1 BOTTLE (0135-0574-01) GAVISCON Haleon US Holdings LLC 2014-08-01
Observed labelers: Haleon US Holdings LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.